Network origin in Matthias Klaften first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
amcure GmbH
 amcure GmbH BiotechnologyHealth Technology amcure GmbH develops active ingredients for the treatment of angiogenesis-related diseases. It offers a peptide based substance, that targets the tumor specific co-receptors. The company was founded by Matthias Klaften and Alexandra Matzke on December 14, 2011 and is headquartered in Eggenstein-Leopoldshafen, Germany.
3
| Holding Company | Biotechnology | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Matthias Klaften via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Speedel Pharma AG
 Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. It researches on Renin Inhibitors and also develops an Endothelin Receptor Anatagonist. The company also operates in the U.S. and Japan. It was founded in 1998 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
| BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SPEXIS AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree |
Statistics
International
| Germany | 4 |
| Switzerland | 3 |
Sectoral
| Health Technology | 4 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Operational
| Corporate Officer/Principal | 4 |
| Chief Executive Officer | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Founder | 1 |
Most connected contacts
| Insiders | |
|---|---|
| Klaus Dembowsky | 6 |
| Alexandra Matzke | 1 |
| Silvia Giordano | 1 |
- Stock Market
- Insiders
- Matthias Klaften
- Company connections
